AKZO NOBEL NV
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Akzo Nobel
Chemicals & Allied Products, SIC 2800
Akzo Nobel N.V. produces and supplies healthcare products, coatings, and chemicals. The company operates through four principal business segments: human pharmaceuticals, animal health, coatings, and chemicals. Its human pharmaceutical operations develop and manufacture prescription medicines targeting fertility, gynecology, and anesthesia, while its animal health business supplies vaccines and pharmaceuticals for livestock, aquatic species, and companion animals. The coatings segment produces architectural paints and industrial coatings, and the chemicals division manufactures pulp and paper chemicals, base chemicals, functional chemicals, surfactants, and polymer chemicals. The company serves industrial, medical, and consumer customers worldwide.
The organization operates through subsidiaries in more than 80 countries and employs approximately 62,000 people. Its activities are conducted across Western Europe, the United States, and Asia, alongside presence in Eastern Europe, Southeast Asia, and Latin America. The company maintains its principal executive offices and headquarters in Arnhem, the Netherlands.
Summary of the business section of Akzo Nobel's latest annual report, written by StockData.
Company profile
Company
- Legal name
- AKZO NOBEL NV
- Headquarters
- Amsterdam, Netherlands
- Address
- Christian Neefestraat 2 1077 WW
- Phone
- 31889691802
- Website
- akzonobel.com
- Employees
- 62,000, Dec 31, 2006
- Industry
- Chemicals & Allied Products
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- AKZOY
- Other tickers
- AKZOF
- Exchange
- OTC
- IPO date
- May 9, 1989
- Stock splits
- 3-for-1, Jan 4, 2012; 2-for-1, Jul 1, 1998
- SEC CIK
- 3124
- CUSIP
- 010199503
- ISIN
- US0101995035
- LEI
- 724500XYIJUGXAA5QD70
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Akzo Nobel's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We employ around 62,000 people and conduct our activities in four segmentshuman and”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 28, 2026 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Sep 28, 2007 | Deregistration | Termination of SEC registration (Form 15) |
| Aug 15, 2007 | Delisting | Notice of delisting from exchange (Form 25) |